GC Wealth Management RIA’s Thermo Fisher Scientific TMO Stock Holding History

GC Wealth Management RIA’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.66M	Sell	13,285 -3,622	-21%	-$1.74M	0.38%	54
2026 Q1	$8.31M	Buy	16,907 +573	+4%	+$311K	0.34%	44
2025 Q4	$9.46M	Sell	16,334 -3,403	-17%	-$1.92M	0.35%	40
2025 Q3	$9.57M	Buy	19,737 +9,884	+100%	+$4.6M	0.32%	48
2025 Q2	$3.99M	Buy	9,853 +5,005	+103%	+$2.09M	0.33%	62
2025 Q1	$2.41M	Sell	4,848 -216	-4%	-$117K	0.44%	59
2024 Q4	$2.63M	Sell	5,064 -826	-14%	-$454K	0.46%	50
2024 Q3	$3.64M	Buy	5,890 +1,648	+39%	+$976K	0.64%	32
2024 Q2	$2.35M	Buy	4,242 +539	+15%	+$309K	0.46%	44
2024 Q1	$2.15M	Buy	3,703 +1,749	+90%	+$981K	0.43%	45
2023 Q4	$1.04M	Buy	+1,954	New	+$946K	0.47%	59

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

GC Wealth Management RIA's TMO Position: Q2 2026 in Review

GC Wealth Management RIA reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q2 2026, selling an estimated $1.74M and leaving 13,285 shares worth $6.66M. The position accounts for 0.38% of the portfolio, ranked #54.

GC Wealth Management RIA first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.57M in Q3 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

GC Wealth Management RIA held 13,285 shares of Thermo Fisher Scientific worth $6.66M as of Q2 2026.
GC Wealth Management RIA sold 3,622 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.74M.
Thermo Fisher Scientific made up 0.38% of GC Wealth Management RIA's portfolio in Q2 2026, its #54 holding.
GC Wealth Management RIA first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
GC Wealth Management RIA's Thermo Fisher Scientific position peaked at $9.57M in Q3 2025.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.